Intellectual Property, Pharmaceuticals and Public Health

Access to Drugs in Developing Countries

Häftad, Engelska, 2013

AvKenneth C. Shadlen,Samira Guennif,Alenka Guzmán,Narayanan Lalitha

709 kr

Beställningsvara. Skickas inom 7-10 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.

This up-to-date book examines pharmaceutical development, access to medicines, and the protection of public health in the context of two fundamental changes that the global political economy has undergone since the 1970s, the globalization of trade and production and the increased harmonization of national regulations on intellectual property rights. With authors from eleven different countries presenting case studies of national experiences in Africa, Asia and the Americas, the book analyzes national strategies to promote pharmaceutical innovation, while at the same time assuring widespread access to medicines through generic pharmaceutical production and generic pharmaceutical importation. The expert chapters focus on patents as well as an array of regulatory instruments, including pricing and drug registration policies. Presenting in-depth analysis and original empirical research, this book will strongly appeal to academics and students of intellectual property, international health, international political economy, international development and law. Contributors: T. Andia, M. Bourassa Forcier, M. Flynn, P. Gehl Sampath, S. Guennif, A. Guzman, H. Klug, G. Krikorian, N. Lalitha, J.-F. Morin, K.C. Shadlen, L. Shi, M. Watanabe

Produktinformation

Utgivningsdatum2013-05-31
Mått156 x 234 x undefined mm
FormatHäftad
SpråkEngelska
FörlagEdward Elgar Publishing Ltd
ISBN9780857938794

Tillhör följande kategorier

Tillverkningsindustri inom Ekonomi och Ledarskap
Immaterialrätt inom Juridik

Contents:1. Globalization, Intellectual Property Rights, and Pharmaceuticals: Meeting the Challenges to Addressing Health Gaps in the New International EnvironmentKenneth C. Shadlen, Samira Guennif, Alenka Guzmán and N. Lalitha2. Pharmaceutical Production and Access to Essential Medicines in South AfricaHeinz Klug3. Intellectual Property and Access to Medicines: Paradoxes in Moroccan Policy Gaëlle Krikorian4. The Invisible Threat: Trade, Intellectual Property, and Pharmaceutical Regulations in ColombiaTatiana Andia5. The Challenges of Constructing Pharmaceutical Capabilities and Promoting Access to Medicines in Mexico under TRIPSAlenka Guzmán6. Corporate Power and State Resistance: Brazil’s Use of TRIPS Flexibilities for its National AIDS ProgramMatthew Flynn7. The Politics of Patents and Drugs in Brazil and Mexico: The Industrial Bases of Health PoliciesKenneth C. Shadlen8. Pharmaceutical Patent Policy in Developing Countries: Learning from the Canadian ExperienceJean-Frédéric Morin and Mélanie Bourassa Forcier9. Access to Indian Generic Drugs: Emerging IssuesN. Lalitha10. Sufficient but Expensive Drugs: A Double-Track System that Facilitated Supply Capability in ChinaMariko Watanabe and Luwen Shi11. Access to Essential Drugs in Thailand: Intellectual Property Rights and Other Institutional Matters Affecting Public Health in a Developing CountrySamira Guennif12. The TRIPS Agreement and Health Innovation in BangladeshPadmashree Gehl Sampath Index

‘. . . this book will appeal strongly to a wide range of professionals, academics and students with interest in and involvement in public health issues worldwide, specifically the pharmaceutical industry. . . the book is timely, topical, and packed with carefully researched information which puts a number of major issues relating to pharmaceuticals in perspective. Of great value to researchers are the copious footnotes and extensive bibliographies which follow most of the articles. . . this book certainly provides you with an impressive mine of information if you find yourself having to argue your corner on any number of legal, economic and ethical issues in this complex field of study.’